MicroPort NeuroScientific Corporation (HKG:2172)

Market Cap	7.52B
Revenue (ttm)	810.65M
Net Income (ttm)	270.48M
Shares Out	575.53M
EPS (ttm)	0.47
PE Ratio	27.96
Forward PE	25.97
Dividend	0.22 (1.64%)
Ex-Dividend Date	Jul 2, 2025

Volume	7,218,000
Average Volume	13,941,793
Open	13.20
Previous Close	13.06
Day's Range	12.76 - 13.20
52-Week Range	6.80 - 19.06
Beta	-0.10
RSI	55.10
Earnings Date	Aug 26, 2025

About MicroPort NeuroScientific

MicroPort NeuroScientific Corporation provides neuro-interventional medical devices. The company offers NUMEN, a coil embolization system; NUMEN FR, a coil detachment system; NUMEN Silk, a 3D electronically detachable coil; Numen Lighting, a coil embolization system; Numen Nest, a detachable coil; NuFairy absorbable coil embolization system; Tubridge, a flow-diverting stent; Tubridge Plus, a flow-diverting stent; WILLIS, a intracranial stent graft system; Comaneci, a embolization assist device; and Rebridge, an intracranial visualized stent for...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 527
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2172

Financial Performance

In 2024, MicroPort NeuroScientific's revenue was 761.76 million, an increase of 14.44% compared to the previous year's 665.62 million. Earnings were 254.17 million, an increase of 74.63%.

Financial numbers in CNY